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Summary
Normal bone marrow (BM) contains T cells whose func-
tion and origin are poorly understood. We observed
that CD8+ T cells in BM consist chiefly of CCR7+
L-selectin+ central memory cells (TCMs). Adoptively
transferred TCMs accumulated more efficiently in the
BM than naive and effector T cells. Intravital micro-
scopy (IVM) showed that TCMs roll efficiently in BM
microvessels via L-, P-, and E-selectin, whereas firm
arrest required the VCAM-1/41 pathway. 41 inte-
grin activation did not depend on pertussis toxin
(PTX)-sensitive Gi proteins but was reduced by anti-
CXCL12. In contrast, TCM diapedesis did not require
CXCL12 but was blocked by PTX. After extravasation,
TCMs displayed agile movement within BM cavities,
remained viable, and mounted potent antigen-specific
recall responses for at least two months. Thus, the
BM functions as a major reservoir for TCMs by provid-
ing specific recruitment signals that act in sequence
to mediate the constitutive recruitment of TCMs from
the blood.
Introduction
Although the importance of the BM in hematopoiesis is
well known, its function in T cell-mediated immunity is
only partly understood. Studies in mice have shown
that the BM accumulates activated/memory T cells af-
ter exposure to environmental cognate antigens (Ags)
(Price and Cerny, 1999) and promotes the long-term
persistence of antiviral memory cells (Kuroda et al.,
2000; Marshall et al., 2001; Slifka et al., 1997). In some
circumstances, it can even support the priming of naive
T cells (Feuerer et al., 2003; Tripp et al., 1997). BM-resi-*Correspondence: uva@cbr.med.harvard.edu
5 Present address: Wistar Institute, Philadelphia, Pennsylvania
19104.dent T cells are also important for BM transplantation
(BMT) because contaminating T cells in BM allografts
can cause graft versus host disease (GvHD). On the
other hand, T cell depletion from allogenic BM grafts
compromises engraftment (Martinez et al., 1999) be-
cause CD8+ (but not CD4+) T cells and dendritic cells
(DCs) facilitate engraftment (Adams et al., 2003; Gandy
et al., 1999; Zeng et al., 2002). Indeed, BM-resident T
cells are functionally distinct from those in other com-
partments. Compared to their blood-derived cousins,
BM-derived CD8+ T cells induce milder GvHD and tu-
mor-specific cytotoxic lymphocytes (CTL) are more fre-
quent and possess higher antitumor activity in BM than
in blood of cancer patients (Feuerer et al., 2001a,
2001b; Zeng et al., 2002). Thus, the BM is being consid-
ered with growing interest as a source of T cells for
cancer therapy (Schirrmacher et al., 2003).
Here, we asked how T cells accumulate in the BM
and how they differ from T cells elsewhere. BM stroma
cells can support lymphoid precursor cell differentia-
tion into mature T cells in vitro (Garcia-Ojeda et al.,
1998) and in athymic mice in vivo (Tsark et al., 2001).
However, T cells in wild-type (wt) BM are probably im-
migrants from the blood because T cells are normally
produced in the thymus. Indeed, the BM continuously
recruits circulating hemopoietic stem cells (HSCs) (Wright
et al., 2001) because BM microvessels constitutively
express prerequisite traffic molecules (Mazo and von
Andrian, 1999), which might also support homing of T
cell subsets.
After exiting the thymus, naive T cells search for Ag
by recirculating between blood and secondary lym-
phoid organs (SLOs). Upon Ag stimulation, T cells pro-
liferate and become effector cells (TEffs); CD8+ TEffs
produce cytokines, especially interferon (IFN)-γ, and
become CTL. Upon Ag clearance most TEffs die, but a
few give rise to memory cells providing long-term pro-
tection. Memory cells are subdivided into two subsets
based on their migration pattern (Sallusto et al., 1999):
effector memory cells (TEMs) migrate to peripheral tis-
sues to eliminate pathogens, whereas TCMs express
homing molecules, allowing them to migrate to SLOs,
particularly lymph nodes (Weninger et al., 2001).
We show here that TCMs constitute the largest en-
dogenous subset of CD8+ T cells in murine BM and are
also prominent in human BM. Accordingly, adoptively
transferred TCMs from immunized mice colonized recip-
ient BM more effectively than TEMs and naive T cells.
The mechanisms by which in vivo-generated memory
cell subsets are recruited to tissues have been difficult
to study, because such studies require unattainable
numbers of purified cells. We were able to circumvent
this obstacle by using a recently described in vitro
method to generate Ag-specific TEffs and TCMs from
TCR transgenic CD8+ T cells (Manjunath et al., 2001).
After i.v. injection, naive T cells and TCMs were more
efficiently recruited to the BM than TEffs. Adoptively
transferred TCMs were much more efficiently retained in
the BM than other subsets and mounted potent recall
responses upon restimulation. By using IVM, we have
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260dissected the multistep adhesion cascade for TCM re-
cruitment to the BM and show that extravasated TCMs
move actively within BM cavities.
Results
TCMs Are the Predominant Subset among CD8+
T Cells in Murine BM
To investigate CD8+ T cell traffic in normal BM, we com-
pared the composition of CD8+ T cells in BM, blood,
and SLOs of adult mice. CD8+ T cells comprised 2.5% ±
0.1% of all mononuclear cells (MNCs) in the BM, which
is a much smaller fraction than in blood (7.9% ± 1.8%)
or spleen (11.8% ± 0.1%; Figure 1A). Two-thirds of BM-
resident T cells expressed surface markers indicative
of Ag experience, i.e., they were CD44hi and CD122+,
whereas most CD8+ T cells in spleen, peripheral lymph
nodes (PLNs), and blood were naive (i.e., CD44lo/−
CD122−; Figure 1B). Thus, the BM differs from classic
SLOs in terms of its accumulation of memory cells.
Memory T cells are subdivided based on their ex-
pression of CCR7 (Sallusto et al., 1999). TCMs are
CCR7+ and mostly coexpress L-selectin. They home ef-
ficiently to PLN and other SLOs, whereas CCR7− TEffs
and the longer-lived TEMs are largely L-selectin– and ac-
cumulate in nonlymphoid tissues and to some degree
in the spleen (Sallusto et al., 1999; Weninger et al.,
2001). Thus, we examined CCR7 expression on CD44hi
(memory) and CD44lo (naive) CD8+ T cells by using
CCL19-Ig chimera as a probe (Manjunath et al., 2001).
As expected, naive T cells in all organs were CCR7+
and L-selectin+, whereas CD44hi T cells expressed
these markers variably (Figure 1C). CCR7− TEMs bound
P-selectin (Table S1 available with this article online
and data not shown) and represented approximately
half of all memory cells in spleen and blood. By con-
trast, TEMs were more sparse among BM CD8 cells
where the largest subset was comprised of CCR7+L-
Fselectin+ TCMs that did not bind P-selectin. Conse- a
quently, although the spleen harbored many more naive
(
CD8+ T cells and TEMs than the BM, the number of TCMs a
was similar in both organs. Thus, mouse BM is a major A
reservoir for Ag-experienced CD8+ T cells, most of (
swhich share a TCM phenotype.
bWe also examined CD3+CD8+ T cells in BM from
(healthy human donors by using mAbs specific for CCR7
m
and CD45RA (Sallusto et al., 1999). As shown in Figure i
1D, naive T cells contributed only 21% of CD8+ T cells, (
whereas the largest subsets (w30% each) were TCMs f
((CD45RA−CCR7+) and TEMs (CD45RA−CCR7−); a smaller
mfraction was comprised of TEffs (CD45RA+CCR7−). Similar #
results were obtained with two anti-CCR7 mAbs (clones
S
2H4 and 3D12), whereas a third anti-CCR7 mAb, 6B3
(Hasegawa et al., 2000), stained nearly 70% of
CD45RA− CD8+ T cells (not shown). Thus, mammalian w
BM is a rich source of TCMs not only in mice kept in a f
pathogen-free facility but also in people. l
t
dPreferential Homing and Retention of TCMs in BM
The relatively larger proportion of CCR7− T cells in hu- C
aman versus murine BM might reflect the constant expo-
sure to infectious Ags experienced in normal human life. T
rTo ask if this might also apply to mice, we transferred intoigure 1. Subset Composition of Resident CD8+ T Cells in Murine
nd Human BM
A) The frequency of CD8β+ cells in BM, spleen, and blood of young
dult C57BL6 mice. *p < 0.05 and **p < 0.01 versus BM (one-way
NOVA). Error bars show mean ± SEM.
B) Activation/memory markers on CD8β+ T cells in mouse BM and
pleen. Cell frequencies among all CD8β+ T cells are shown for
oth the naive and memory gate.
C) CCR7 expression, as determined by staining with CCL19-Ig chi-
era, on naive (solid line) and memory (dotted line) CD8β+ T cells
n BM. A histogram for peripheral blood memory CD8+ T cells
dashed line) is shown for comparison. Data are representative of
ive independent experiments.
D) Naive and memory subset frequencies among CD8+ T cells in
urine and human BM. **p < 0.01, ***p < 0.001 versus TCMs, and
##p < 0.001 versus naive T cells (TNs). Error bars show mean ±
EM.t recipients naive P14 CD8+ T cells expressing a TCR
or LCMV gp33–41 in H2-Db. 1 day and again 3 weeks
ater, the mice received i.v. injections of mature pep-
ide-pulsed DCs. After 5 more weeks, all CD8+ T cells
etected by a P14 TCR-specific MHC tetramer were
D44high in both BM and spleen. At least as many TEMs
s TCMs were found in recipients’ spleens, whereas
CMs in BM outnumbered TEMs. However, the TCM/TEM
atio in BM after Ag challenge (1.8:1) was markedly re-
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261duced compared to untreated pathogen-free mice
(4.4:1), indicating that mouse BM can harbor substan-
tial numbers of newly generated memory cells other
than TCMs (Figure S1).
Next, we asked whether the prevalence of TCMs in
BM could be explained by their migratory properties.
Thus, P14 memory cells were generated in vivo as
above, and purified T cells (CD45.2+ containing 1.01%
tetramer+ cells) were transfused into CD45.1 recipients.
2 hr later, tetramer+ memory cells were markedly en-
riched among CD45.2+ T cells in recipient spleens and,
especially, BM compared to their input frequency (Fig-
ure 2A). This effect was mostly due to selective accu-
mulation of TCMs, which became 3.5-fold enriched in
both tissues compared to TEMs. Nevertheless, the
tetramer+ TEM concentration in BM was significantly
higher than in the input, indicating TEMs have enhanced
BM tropism, albeit less pronounced than TCMs.
To identify the molecular mechanisms of memory
CD8+ T cell homing to the BM, much larger numbers of
purified memory subsets are needed than for simple
homing experiments. Because it is not practical to ob-
tain the required cell numbers from immunized mice,
we resorted to in vitro production of TEffs and TCMs from
naive T cells (Manjunath et al., 2001). We used T-GFP×Figure 2. Subset-Specific CD8+ T Cell Hom-
ing to the BM
(A) P14 TCMs and TEMs (CD45.2+) were gen-
erated in vivo and injected into CD45.1+ re-
cipients. Frequencies of TCMs (MHC-Tet+
CCR7+) and TEMs (MHC-Tet+ CCR7−) among
CD45.2+ donor cells in BM and spleen were
compared with their input frequency. *p <
0.05, **p < 0.01, and ***p < 0.001 versus in-
put. #p < 0.05 and ##p < 0.01 versus corre-
sponding subset in BM (paired Student’s t
test). $p < 0.05 versus TCMs. Error bars show
mean ± SEM.
(B and C) Homing of in vitro-generated TCMs,
TEffs, and naive CD8+ T cells at 2 hr (B) or 24
hr (C) after adoptive transfer. A homing index
(HI) of 2 means that Ag-experienced cells
were twice as frequent as naive T cells,
whereas HI = 1 means that both samples
were equivalently represented and so on.
Mean ± SEM of at least four mice are shown
per group. *p < 0.05, **p < 0.01, and ***p <
0.001 versus HI of TEffs (one-way ANOVA).
(D) Numbers of homed cells recovered from
BM at 2 hr and 24 hr after transfer (mean ±
SEM).
(E) Dose-response relationship of homed
TCMs recovered from BM 2 hr after transfer
of different numbers of TCMs.
(F) Representative 3D projection of optical
image stacks obtained by MP-IVM showing
homed TCMs in murine skull BM. Hoechst
33342-labeled TCMs (blue) were injected i.v.
3 hr prior to the recording. The intravascular
compartment was delineated by i.v. injection
of FITC-dextran (green, “F”). Extravascular
hemopoietic tissue was stained with rhoda-
mine 6G (red, “R”). Arrow indicates transmi-
grating cell. For a 3D video of this scene
refer to Movie 1; for a time-lapse video
showing TCMs migration in BM cavities refer
to Movie 2.P14 mice, in which naive T cells and TCMs express GFP,
and effector CTLs become GFP− (Weninger et al., 2002).
Peptide-primed T-GFP×P14 T cells can be differentiated
into GFP− TEffs or GFP+ TCM-like cells by several days
exposure to IL-2 (CD8IL-2) or IL-15 (CD8IL-15), respectively
(Manjunath et al., 2001). Their response to recall Ag and
ability to migrate to SLOs and inflamed tissue were de-
scribed previously (Goodarzi et al., 2003; Manjunath et
al., 2001; Weninger et al., 2001). In vitro differentiated
CD8IL-2 and CD8IL-15 cells are phenotypically similar to
endogenous BM-resident TEMs and TCMs, respectively.
This applies to the expression numerous traffic mole-
cules, including CCR7; CXCR4; L-selectin; the integrins
CD11a, CD11b, α4, α5, and α4β7; as well as PSGL-1
(Manjunath et al., 2001; Weninger et al., 2001 and data
not shown). Thus, CD8IL-15 and CD8IL-2 cells represent
faithful surrogates for bona fide TCMs and TEffs, respec-
tively, and will be referred to under these names below.
To determine whether in vitro-differentiated TCMs and
TEffs migrate similarly to memory cells induced in situ,
TCMs and TEffs were labeled red with TRITC and mixed
with T-GFP×P14 splenocytes containing w30%–35%
naive GFP+CD8+ T cells, which served as a reference.
Cells were injected into naive mice and the homing in-
dex (HI; the ratio of TRITC+:GFP+ naive cells) was deter-
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262mined in various tissues 2 or 24 hr later. At 2 hr after
injection, TCMs were most prominent in the blood,
whereas naive T cells homed best to SLOs (Figure 2B).
TEffs were recovered from all recipient tissues and the
blood but at a lower concentration, probably because
many of these relatively large blasts were sequestered
in lung and liver (Weninger et al., 2001). The BM was
the only organ containing equivalent numbers of TCMs
and naive T cells at 2 hr after injection.
At 24 hr after transfer, the HI of TCMs and naive T
cells was equivalent in PLN and blood and increased in
the spleen, consistent with previous findings (Weninger
et al., 2001) (Figure 2C). Although naive T cells were
most frequent in the blood, the HI in BM had increased
significantly for TCMs and, to a lesser degree, also for
TEffs. This shift in HI in the BM between 2 and 24 hr is
explained by the fact that both naive T cells and TCMs
were rapidly and efficiently recruited to the BM, but
only TCMs were retained at this site, whereas naive T
cells returned quickly to the circulation (Figure 2D). TEffs
homed less well to the BM, but they too were efficiently
retained. Thus, our homing experiments are in excellent
agreement with our analysis of endogenous BM-resi-
dent T cells. Of note, there was a linear relationship
between the number of homed and injected TCMs (Fig-
ure 2E), indicating that homing was not limited by com-
petition with endogenous cells or the BM’s capacity to
Frecruit TCMs.
(
i
TCM Diapedesis and Migration within BM Cavities c
Having determined that TCMs possess BM tropism, we v
(focused our further analysis on this subset. First, we
Remployed multiphoton IVM to observe TCMs within BM
Rcavities in skulls of anesthetized mice (Mazo et al.,
s
1998). Optical serial sections were rendered as 3D (
images of BM cavities in which blood vessels were de- t
lineated by FITC-dextran (green) and hemopoietic tis- t
(sue was stained with rhodamine 6G (red). Extravascular
sTCMs carrying blue fluorescence were found within 3 hr
(after injection (Figure 2F, Movie 1). 3D time-lapse mov-
c
ies showed that the homed TCMs were highly motile and (
migrated at 6.5 ± 0.2 m/min (mean ± SEM, n = 189 m
cells), often over long distances (Movie 2). TCM move- p
Bment was confined to the rhodamine 6G-filled BM cavi-
sties and did not occur in adjacent bone but otherwise
was random in direction.
TTCMs Adhere More Efficiently to BM
mMicrovessels than TEffs
NNext, we performed epifluorescence-based video IVM
tin skull BM (Figure 3). Although this technique does not
(permit 3D imaging, the fast acquisition rate (30 frames/s)
eis useful to dissect the molecular mechanisms of rapid
ladhesion events (Mazo et al., 1998). Fluorescently la-
tbeled naive CD8+ T cells, TCMs or TEffs were injected
tinto anesthetized mice and their passage through BM
microvessels was recorded (Movie 3). TCMs rolledw1.6
times more frequently in BM vessels than TEffs, and the S
ifrequency at which rolling cells arrested (sticking frac-
tion) was w2.2-fold higher (Figure 3A). Consequently, N
athe frequency at which cells entering a microvessel
completed the entire multistep adhesion cascade α
m(sticking efficiency) was 3.8-fold higher for T s thanCMigure 3. Adhesion Pathways for TCM Homing to BM
A) TCMs display higher intravascular adhesiveness than TEffs. Roll-
ng fractions (RFxs), sticking fractions (SFxs), and sticking effi-
iencies (SEs) of TCMs and TEffs were analyzed in the same micro-
essels. *p < 0.05 versus TCMs. Error bars show mean ± SEM.
B) Effect of mAbs on TCM rolling in BM venules and sinusoids.
esults are shown as RFxs after mAb treatment normalized to
Fxs in the same vessel prior to mAb injection (control). Error bars
how mean ± SEM.
C) TCM rolling in PSGL-1−/− mice is significantly lower than in wild-
ype (wt) littermates (right) but is insensitive to anti-L-selectin injec-
ion (left). Error bars show mean ± SEM.
D) Effect of blocking mAbs to VCAM-1 and β7 integrins on TCM
ticking in BM microvessels. Error bars show mean ± SEM.
E) Sticking, but not rolling, of TCMs is compromised in VCAM-1
onditional knockout mice. Error bars show mean ± SEM.
F) TCM homing (24 hr) in VCAM-1−/− mice. Data are presented as
ean ± SEM from three to five animals. Results were compared by
aired Student’s t test (A, C, E, and F) or one-way ANOVA with
onferroni correction (B and D). *p < 0.05, **p < 0.01, and ns = not
ignificant versus control or wt. Error bars show mean ± SEM.Effs. These findings agree well with our homing experi-
ents and analysis of BM resident memory subsets.
aive T cells underwent rolling and sticking interac-
ions that were similar in frequency to those of TCMs
data not shown) and in line with short-term homing
xperiments (Figure 2B). However, the low frequency of
ong-term resident naive T cells suggests that addi-
ional, as yet unidentified, factors influence the magni-
ude of steady-state CD8+ T cell subsets in BM.
electins, but Not 4 Integrins, Mediate TCM Rolling
n BM Microvessels
ormal BM sinusoids express P- and E-selectin as well
s VCAM-1 (Mazo et al., 2002). The latter is a ligand for
4β1 (VLA-4), which mediates stem cell rolling in BM
icrovessels (Mazo et al., 1998). However, T rollingCM
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263was normal in BM of wt mice treated with anti-VCAM-1
(Figure 3B) and in mice with a conditional deficiency in
endothelial VCAM-1 (Figure 3E). Moreover, TCM treat-
ment with anti-β7 had no effect, indicating that α4β7 is
also not involved. By contrast, anti-L-selectin reduced
rolling by 64%, whereas mAbs to P- and E-selectin at-
tenuated it by 49% and 46%, respectively (Figure 3B).
TCM rolling was also reduced by 48% in mice deficient
in PSGL-1, a major selectin ligand (Figure 3C, right).
A combination of mAbs to P- and E-selectin blocked
additively (by 78%), but there was no further inhibition
when anti-L-selectin was added. This suggests that
L-selectin mediated secondary tethering whereby en-
dogenous leukocytes adhere to P- and/or E-selectin in
BM microvessels and present PSGL-1 as an L-selectin
ligand to circulating TCMs (Bargatze et al., 1994; Fuhl-
brigge et al., 1996; Walcheck et al., 1996). Indeed, anti-
L-selectin had no effect on TCM rolling in BM of PSGL-
1-deficient mice (Figure 3C, left). Thus, the endothelial
selectins in BM microvessels interact with PSGL-1 on
circulating TCMs, whereas L-selectin on TCMs likely con-
tributes indirectly by allowing TCMs to tether to other
adherent leukocytes.
The VCAM-1/41 Pathway Mediates TCM
Sticking in BM
In most in vivo settings, rolling leukocytes can only ar-
rest by using activation-dependent integrins (von An-
drian and Mackay, 2000). Because both the β2 integrin
LFA-1 and the α4 integrin VLA-4 are highly expressed
on TCMs (not shown), we examined these pathways.
However, although TCMs use LFA-1 to arrest in PLN HEV
(Weninger et al., 2001), anti-LFA-1 had no effect on TCM
sticking in BM venules or sinusoids (data not shown).
By contrast, anti-VCAM-1, the major vascular ligand for
VLA-4, reduced TCM sticking by 77% (Figure 3D) and
TCM sticking was also 72% lower in conditional VCAM-1
knockout mice than in wt mice (Figure 3E). The impor-
tance of VCAM-1 was confirmed in homing experi-
ments; the BM of conditional VCAM-1 knockout mice
recruited significantly fewer TCMs than wt BM (Figure
3F). However, it is possible that this result reflects not
only decreased TCM sticking, because VCAM-1 might
also participate in subsequent diapedesis. TCMs also
express α4β7 (data not shown), which can bind to
VCAM-1, but inhibition of this integrin did not affect
sticking (Figure 3D). Therefore, VCAM-1–VLA-4 is the
principal pathway for TCM arrest in BM microvessels.
However, because sticking was not completely abol-
ished without VCAM-1, there is probably at least one
additional mechanism for TCM sticking.
PTX-Sensitive G Protein Signaling Is Required
for Optimal TCM Homing, but Not for Integrin
Activation in the BM
Integrins support leukocyte sticking only in their high-
affinity conformation, which requires activation signal(s)
from chemoattractant receptor(s). G protein-coupled
receptors (GPCRs), e.g., those for chemokines, can
rapidly transmit integrin activation signals. Because
most chemoattractant receptors signal through Gαi,
they are inhibitable by PTX. Therefore, we performed
competitive homing assays comparing differentially la-beled, PTX-treated TCMs with sham-treated control
cells. As expected, 2 hr after injection, significantly
fewer PTX-treated TCMs had homed to PLN, MLN, and
BM, whereas more PTX-treated TCMs than untreated
cells continued to circulate (HI: 3.4 ± 0.7; Figure 4A).
However, although PTX virtually abolished TCM homing
to LNs, its effect in the BM was only partial (w60%,
inhibition), indicating that Gαi-coupled signals are not
absolutely required for TCM lodging in the BM. Results
were similar at 24 hr after TCM injection (Figure 4B), ex-
cept that the difference in circulating cell numbers was
less pronounced.
Because homing experiments cannot distinguish be-
tween intra- and extravascular TCMs in the BM, we
asked whether PTX blocked TCM sticking, transmigra-
tion, or both. By using 2D epifluorescence and 3D
multiphoton IVM, we compared the ability of PTX-
treated and control TCMs to interact with BM microves-
sels and to emigrate into BM cavities, respectively. PTX
had no significant effect on TCM rolling and, surpris-
ingly, the frequency at which rolling cells arrested was
also not different from controls (Figure 5C). By contrast,
the fraction of PTX-treated TCMs that remained lumi-
nally adherent without emigrating was significantly
larger than that of control cells (Figure 4C). Conse-
quently, the ratio of extra- to intravascular control TCMs
was twice as high as that of PTX treated TCMs (Figure
4D, Movie 4). Thus, intravascular integrin activation of
rolling TCMs is independent of Gαi signals, whereas the
subsequent diapedesis step depends partially on
such signals.
CXCL12 Induces TCM Sticking, but Not Diapedesis,
in BM Microvessels
The chemokine CXCL12 is highly expressed in normal
BM (Bleul et al., 1996; Nagasawa et al., 1994). Its recep-
tor CXCR4 is upregulated on memory T cells by IL-15
(Jourdan et al., 2000), and CXCL12 can induce TCM
sticking in mouse cremaster muscle venules and PLN
HEV (Scimone et al., 2004). Indeed, TCMs, but not TEffs,
migrated toward a CXCL12 gradient in vitro (Figure 5A).
This chemotactic response of TCMs was similar to that
of naive T cells (not shown) and sensitive to PTX (Figure
5A, inset).
When groups of mice were treated with anti-CXCL12
or an isotype control mAb, TCM homing to the spleen
was undisturbed, but homing to the BM of recipients
of anti-CXCL12 was significantly reduced (by 37.5%;
Figure 5B). Because these results indicated that both
PTX and anti-CXCL12 had a similar, if partial, impact
on TCM recruitment to the BM, and TCM chemotaxis to
CXCL12 was blocked by PTX, it seemed reasonable
that the PTX effect was due to inhibition of Gαi signal-
ing via CXCR4. Given our findings with PTX-treated
TCMs, this hypothesis predicted that CXCL12 should be
required for TCM diapedesis, but not for sticking. Sur-
prisingly, IVM experiments with anti-CXCL12 yielded
the opposite result. In contrast to PTX, anti-CXCL12 re-
duced TCM sticking in BM microvessels; the sticking
fractions before and after mAb treatment were 38 ± 5%
and 21 ± 4%, respectively (p < 0.01; Figure 5C). Anti-
CXCL12 also reduced the sticking fraction of TCMs that
had been pretreated with PTX by 47%. Indeed, it ap-
Immunity
264Figure 4. Effect of PTX on TCM Homing and
Transmigration
Recipients were sacrificed 2 hr (A) or 24 hr
(B) after injection, and homing indices were
calculated in indicated organ as ratio of
homed PTX-treated cells to control cells (n =
4). Error bars show mean ± SEM.
(C) Representative 3D projection of MP-IVM
image stacks demonstrating control (blue)
and PTX-treated (red) TCM localization in
skull BM 3 hr after injection. Microvessels
were contrasted by FITC-dextran (green). A
3D video of this scene is shown in Movie 4.
(D) Transmigration efficiency (ratio of extra-
to intravascular cells in the same field of
view) of PTX treated and control TCMs. Data
are from 10 to 12 fields in each of three ex-
periment (mean ± SEM).
Results were compared by one-way ANOVA
with Bonferroni correction (A and B) or
paired Student’s t test (D). *p < 0.05, **p <
0.01, and ***p < 0.001 versus control.pears that the effect of CXCL12 in TCM traffic to the v
TBM does not at all involve Gαi signaling, because anti-
CXCL12, unlike PTX, did not interfere with the ability of o
osticking TCMs to emigrate (Figure 5D).
These results demonstrate that CXCL12 in BM micro- sequentially during BM colonization, interruption of
Figure 5. Role of CXCL12 in TCM Homing
to BM
(A) TCMs possess higher chemotactic activity
toward CXCL12 than TEffs. Inset, effect of
PTX on TCM migration to 500 ng/ml CXCL12.
Error bars show mean ± SEM.
(B) Effect of PTX and anti-CXCL12 on TCM
homing to BM and spleen. Error bars show
mean ± SEM.
(C) Effect of PTX and anti-CXCL12 on TCM
sticking in BM microvessels. Error bars show
mean ± SEM.
(D) Transmigration efficiency of TCMs across
BM microvessels in control and anti-CXCL12-
treated mice. Bars represent mean ± SEM
from three to five animals. Results were
compared by paired Student’s t test (A and
C) or one-way ANOVA with Bonferroni cor-
rection (B). *p < 0.05, **p < 0.01, and ns =
not significant.essels triggers integrin-dependent, Gαi-independent
CM sticking, but Gαi-coupled signals are required for
ptimal TCM emigration, which is probably independent
f CXCL12. Because sticking and transmigration occur
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265either step resulted in partially reduced homing of cir-
culating TCMs to the BM. However, the effect of Gαi
blockade was almost twice as strong as anti-CXCL12,
and simultaneous inhibition of both had only a small
additive effect (Table 1), suggesting that postadhesion
diapedesis is a major rate-limiting event in TCM homing.
Nevertheless, even with combination treatment, one
quarter of the normal number of TCMs continued to ac-
cess the BM, indicating that additional, as yet unknown
mechanism(s) may contribute.
Adoptively Transferred TCMs in Recipient BM Are
Long Lived and Mount Potent Recall Responses
Having dissected the multistep adhesion cascade for
TCM homing to BM, we asked whether immunocompetent
TCMs take up long-term residence in the BM. For this,
TCMs were generated from CD45.2+ OT-IxRAG−/− T cells
(which recognize OVA257–264 in H-2Kb) or P14xTCRα−/−
T cells and adoptively transferred to CD45.1+ congenic
mice. Recipients were sacrificed 8 weeks later to assess
the ability of CD45.2+ T cells in spleen and BM to pro-
duce IFN-γ and IL-2 upon rechallenge. In control recipi-
ents of naive CD8+ T cells from TCR transgenic mice,
the transferred cells became undetectable within 3–5
weeks and no Ag-specific effector activity was de-
tected upon challenge after 8 weeks (data not shown).
By contrast, adoptively transferred TCMs remained de-
tectable in recipient BM and spleen and readily pro-
duced cytokines upon Ag rechallenge, independent on
a particular transgenic system used (Figures 6A–6C).
No significant cytokine production was observed when
T cells were exposed to a control peptide (Figures 6A
and 6B).
Discussion
This study identifies the BM as a major reservoir for
CD8 TCMs that is equal in size to the splenic TCM pool.
TCMs are recoverable from BM for months after transfer
and potently respond to recall Ag. There are also naive
CD8+ T cells and TEMs in BM, but these populations are
smaller (at least in mice) than naive T cells in SLOs or
TEMs in spleen, liver, and lung (Weninger et al., 2001).
Consistent with the TCM-biased composition of BM-
resident T cells, both naive T cells and TCMs were
rapidly recruited to the BM, but only TCMs were retained
for more than a few hours. In vivo-generated TEMs and
in vitro-generated TEffs home less well to the BM, pre-
sumably because IVM data indicate that they adhere
less efficiently to BM vessels. IVM was also used to
dissect the multistep cascade for T adhesion in BMTable 1. Effect of Differential Treatment with PTX and/or anti-CXCL12 on TCM Sticking, Transmigration Efficiency, and Homing
Sticking Transmigration Homing (2 hr)
Treatment (Percentage of Control) (Percentage of Control) (Percentage of Control)
PTX 84.1 ± 12.7 63.8 ± 8.1** 30.1 ± 8.0**
Anti-CXCL12 64.5 ± 16.1* 108.6 ± 13.7 69.1 ± 6.6*
PTX+anti-CXCL12 ND ND 25.8 ± 5.3**
Sticking was determined by 2D epifluorescence IVM, transmigration was determined by 3D MP IVM. *p < 0.05, **p < 0.01 versus control
(paired Student’s t test), and ND = no data. Data are presented from four mice.CMmicrovessels and to demonstrate that extravasated
TCMs migrate vigorously in perivascular BM tissue.
The presence of memory T cells in the BM has been
documented previously (Di Rosa and Santoni, 2002,
2003; Kuroda et al., 2000; Marshall et al., 2001; Price
and Cerny, 1999; Slifka et al., 1997), and it was also
shown that naive and memory T cells home to the BM
(Berlin-Rufenach et al., 1999; Di Rosa and Santoni,
2003). The BM can sometimes even function like a SLO
where naive T cells can be primed to systemic Ag
(Feuerer et al., 2003; Tripp et al., 1997). However, this
study represents the first attempt to compare side-
by-side the BM tropism of naive and Ag-experienced
TCMs, TEMs, and TEffs with identical antigenic speci-
ficity.
To achieve this, we initially used in vivo-generated
memory cells to document preferential recruitment of
TCMs to the BM. We then used a tissue culture ap-
proach to produce TEffs and TCMs and characterized
in detail their adhesive properties in the BM. Culture-
derived TCMs also allowed us to examine their long-
term fate and function. These cytokine-differentiated
cells have been extensively characterized previously
with regard to surface phenotype, immunological func-
tion, mRNA expression profile, and migration in tissues
other than the BM (Goodarzi et al., 2003; Manjunath et
al., 2001; Ott et al., 2003; Wan et al., 2003; Weninger et
al., 2001). Experiments have shown that both in vitro-
and in vivo-generated TCMs survive after adoptive
transfer for several months and mount more potent Ag-
specific recall responses than TEffs or TEMs (Manjunath
et al., 2001; Wherry et al., 2003). However, the anatomi-
cal site(s) that shelters TCMs has not been identified.
Our experiments suggest that the BM is one of these
sites.
That TCMs possess BM tropism confirms and ex-
pands earlier findings that the migratory routes of TCMs
are distinct from those of other T cells (Sallusto et al.,
1999; Scimone et al., 2004; Weninger et al., 2001;
Wherry et al., 2003). For example, TCMs home to PLN,
whereas TEffs fail to accumulate in SLOs other than the
spleen (Scimone et al., 2004; Weninger et al., 2001).
Conversely, TEffs and TCMs are recruited to the liver and
inflamed tissues, but naive T cells migrate poorly to
these sites (Weninger et al., 2001). However, the BM is
the only organ identified to date that emphasizes the
recruitment of TCMs over all other CD8+ T cells.
To accumulate in tissues, leukocytes undergo a
series of adhesive interactions with microvessels that
are manifested in tethering, rolling, and sticking (Springer,
1994). Although each adhesion step can be mediated
by several receptor-ligand pairs, each leukocyte has at
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266its disposal only a limited, subset-specific set of traffic a
dmolecules. Similarly, microvessels in specialized tis-
sues, such as the BM, constitutively express certain m
ltraffic molecules, which together specify an anatomi-
cally restricted “area code.” Only leukocytes whose T
Lhoming receptor repertoire provides a fit for all adhe-
sion steps have a chance to be recruited. Based on this m
tprinciple, we can explain the distinct migration patterns
of TCMs, TEffs and naive CD8+ T cells (Goodarzi et al., f
O2003; Scimone et al., 2004; Weninger et al., 2001, 2003).
Our IVM study shows that TCM migration to the BM w
tis also a multistep process. This analysis was guided
by earlier findings that BM vessels express VCAM-1 as d
fwell as P- and E-selectin and that HSC require these
molecules for optimal rolling (Mazo et al., 1998, 2002). p
oP/E-selectin also supported TCM rolling but, unlike HSC,
TCMs did not roll via VCAM-1 but utilized L-selectin, o
dwhich is not involved in HSC homing to the BM (Mazo
et al., 1998). L-selectin did not support direct TCM bind- i
ding to BM EC but promoted adhesion to PSGL-1 on
other adherent leukocytes. This secondary tethering p
phenomenon has been observed previously in other
vascular beds (Eriksson et al., 2001; Sperandio et al., a
v2003).
Somewhat surprisingly, TCMs, but not HSCs, utilized B
cL-selectin, although both cell types are L-selectin+.
However, TCMs express more L-selectin than the HSCs α
sthat were previously studied in our IVM model (I.B.M.Figure 6. Long-Term Adoptively Transferred
TCMs in Recipient BM Respond to Recall Ag
(A) Representative dot plots showing intra-
cellular staining of IFN-γ and IL-2 by OT-I
TCMs in recipient BM 8 weeks after adoptive
transfer. TCMs responded to cognate peptide
(SIINFEKL), but not control gp33. Equivalent
results were obtained with P14 TCMs (not
shown).
(B) Frequency of Ag-specific, cytokine-pro-
ducing OT-I and P14 TCMs harvested from re-
cipient spleens and BM 8 weeks after adop-
tive transfer. Data were compared with a
paired Student’s t test. Bars represent mean ±
SEM (n = 3). *p < 0.05, **p < 0.01, and ***p <
0.001 versus gp33.
(C) Number of cytokine producing OT-I TCMs
after stimulation with cognate peptide. *p <
0.05 versus spleen. Error bars show mean ±
SEM.nd U.H.v.A. unpublished data; Mazo et al., 2002). In-
eed, the L-selectin expression level critically deter-
ines a leukocyte’s ability to interact with endothelial
igands (Gauguet et al., 2004; Sperandio et al., 2001;
ang et al., 1998); Accordingly, the fact that TEffs are
-selectin− (Manjunath et al., 2001) can explain why
ore TCMs than TEffs roll in BM vessels because only
he former can form secondary tethers. Consequently,
ewer TCMs rolled in BM of PSGL-1−/− than in wt mice.
n the other hand, TEffs bind soluble P-selectin-Ig,
hereas TCMs do not (Manjunath et al., 2001). Never-
heless, TCMs rolled in BM via endothelial selectins, in-
icating that glycoconjugates on TCMs can bind sur-
ace-expressed selectins in situ, even though they
ossess insufficient affinity for soluble selectins. More-
ver, selectin inhibition probably reduced the number
f adherent leukocytes in BM vessels, which may re-
uce secondary tethering by TCMs. Of note, combined
nhibition of all selectins did not abolish TCM rolling, in-
icating that there are additional unidentified rolling
athways.
Our experiments also suggest that an unidentified
dhesion receptor(s) contributes to TCM sticking in BM
essels. Unlike in other vascular beds, TCM sticking in
M microvessels was insensitive to anti-LFA-1 and in-
ompletely reduced (by 70%–80%) upon inhibition of
4 integrins or VCAM-1, consistent with previous
tudies of integrin involvement in lymphocyte homing
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267to the BM (Berlin-Rufenach et al., 1999; Di Rosa and
Santoni, 2002).
Leukocyte integrins, including α4β1, require a chemo-
attractant stimulus to undergo arrest. CXCL12 is at
least in part responsible for this step in the BM where
CXCL12 is physiologically abundant (Bleul et al., 1996;
Nagasawa et al., 1994; Peled et al., 1999). TCMs express
high levels of CXCR4, which triggers TCM sticking in
other vascular beds (Scimone et al., 2004). By contrast,
TEffs respond poorly to CXL12, presumably because
IL-2 downregulates CXCR4 on T cells (Beider et al.,
2003). This could explain why few rolling TEffs are ar-
rested in BM vessels. On the other hand, PTX treatment
did not reduce TCM sticking in the BM, although it
blocks CXCL12-induced adhesion in PLN HEV (Sci-
mone et al., 2004). Similarly, PTX only partially attenu-
ated TCM traffic to the BM but abolished TCM homing
to PLN in the same recipients, indicating that the PTX
treatment efficiently blocked Gαi-dependent chemo-
kine signals.
It should be noted that PTX-insensitive sticking in BM
microvessels is not unique for TCMs, because fetal liver-
derived HSCs are also not blocked by PTX (Mazo et
al., 2002). CXCR4 can signal through PTX-insensitive G
proteins, such as G12 or Gq (Kehrl, 1998), which can
participate in CXCL12-induced adhesion and migration
(Maghazachi, 1997; Soede et al., 2001; Wright et al.,
2002). However, only high CXCL12 levels, such as those
generated by BM stroma cells, elicit PTX-insensitive
T cell responses. CXCL12 requires Gαi to signal at
lower concentrations, as might be prevalent in PLN
(Poznansky et al., 2000). Further work will be needed to
elucidate why CXCL12 induces Gαi-independent and
Gαi-dependent TCM arrest in BM and PLN, respectively.
Despite its failure to block sticking, PTX treatment
markedly inhibited TCM homing to the BM, presumably
by blocking TCM diapedesis. Thus, a Gαi-dependent
chemoattractant that might be distinct from CXCL12 is
required for TCM diapedesis. Indeed, BM stromal cells
express numerous chemokines (Aman et al., 1993;
Broek et al., 2003; Matzer et al., 2001; Tsujimoto et al.,
1996; Vanderkerken et al., 2002), and TCMs should re-
spond to at least some of them. However, it should be
cautioned that CXCL12 has two isoforms, SDF-1α and
SDF-1β (Tashiro et al., 1993). These splice variants are
subject to differential proteolytic processing, tissue
distribution, and presentation (De La Luz Sierra et
al., 2004). The anti-CXCL12 mAb used here neutral-
izes SDF-1α, but not SDF-1β. Thus, we cannot exclude
that SDF-1β contributed to TCM extravasation, whereas
SDF-1α (and/or additional chemoattractants) triggered
sticking. Indeed, an in vitro study has shown that T cells
adhere to activated endothelium after adsorption of
CXCL12 (Cinamon et al., 2001); although T cell arrest
was PTX-insensitive, subsequent transmigration re-
quired CXCL12-induced Gαi signaling and fluid shear.
Still, TCM homing to BM was not abolished when PTX
and anti-CXCL12 were combined, thus raising the pos-
sibility of an entirely novel recruitment pathway(s).
However, without better reagents, it is difficult to rule
out that this reflects, at least in part, suboptimal in vivo
inhibition of CXCL12, because the mAb used here
blocks TCM chemotaxis to CXCL12 by %85% (data
not shown).What is the benefit of TCM homing to the BM? Mem-
ory CD8+ T cells require IL-15 for long-term survival (Ku
et al., 2000); the BM may be a rich source for this and
other survival factors (Grabstein et al., 1994). Indeed,
adoptively transferred TCMs established residency in
the BM for at least two months. However, this does not
necessarily mean that TCMs spent this entire time in the
BM; there could well be an active steady-state ex-
change between the BM and other SLOs. Indeed, given
that there are substantial numbers of (presumably BM
tropic) TCMs in the blood (Sallusto et al., 1999; Weninger
et al., 2003), we propose that these uniquely immuno-
protective T cells use the BM as a major hub, where
they find transient shelter before engaging in immuno-
surveillance elsewhere. This is consistent with a recent
study showing rapid turnover of CD8 memory cells in
BM of parabiotic mice (Klonowski et al., 2004). How-
ever, there could still exist specialized CD8 populations
in BM that may not be subject to substantial turnover.
For example, the BM is the exclusive residence for a
rare subset of CD8+CD3+ cells that facilitate HSC en-
graftment after BMT (Schuchert et al., 2000).
The concept that BM-resident TCMs are anything but
sessile is further suggested by the observation that
TCMs are constantly moving within BM cavities. Al-
though their migratory velocity was somewhat slower
than that of naive T cells in PLN (Mempel et al., 2004;
Miller et al., 2003), our findings suggest that TCMs in
BM can traverse w400 µm/hr. Unlike in PLN, where
T cell migration resembles a random walk (Miller et al.,
2003), many TCMs in the BM moved preferentially in
close proximity and parallel to venules and sinusoids,
giving the impression that they were searching for
newly extravasated cells. Indeed, in a separate study,
we found that circulating DCs migrate to the BM and
present Ag to resident TCMs (L.L.C., R.B., W.W., I.B.M.
and U.H.v.A., unpublished data).
Experimental Procedures
Mice, mAbs, reagents, tissue culture and chemotaxis methods,
homing experiments, and IVM procedures were described pre-
viously. Details are provided in the Supplemental Data.
In Vivo Generation of TCMs and TEMs
C57Bl/6 donors were implanted with B16 melanoma expressing
Flt3 ligand, and splenic DCs were isolated (Opti-Prep, Sigma) 2
weeks later (Mora et al., 2003). Naive T cells were negatively se-
lected (MACS) from spleens and PLN of P14 mice, and 4 × 106 cells
were injected into young adult C57Bl/6 recipients. 24 hr later, the
mice were injected i.v. with 106 LPS-matured DCs pulsed with 5 g/
ml gp33-41 peptide (BioSource International). Primed mice were
boosted 3 weeks later by injecting 0.5 × 106 Ag-pulsed DCs. After
5 weeks, Ag-specific P14 memory cells were characterized in BM
and spleens by using MHC tetramer H-2Db-PE (Beckman Coulter,
Fullerton, CA). Isolated T cells (2 × 107 CD45.2+) from SLOs and
BM of some immunized mice were transfered to congenic CD45.1
recipients. SLOs and BM were harvested 2 hr later for FACS count-
ing of CD45.2+ MHC tetramer+ TCMs and TEMs.
Multiphoton Microscopy
Multiphoton IVM (MP-IVM) was performed with an Olympus BX50
WI microscope, a MaiTai Ti:Sapphire laser (800 nm excitation;
Spectra Physics), and a BioRad Radiance 2000MP imaging system.
Labeled TCMs were detected through bandpass emission filters at
450/80 nm (for Hoechst 33342) or 600/100 nm (for CMTMR). Ves-
sels were visualized after injection of 2 MDa FITC-dextran (525/30
Immunity
268nm filter). The 450/80 nm filter was also used to detect autofluores- B
Wcence and second harmonic emission from connective tissue. Im-
age stacks were collected at 3–5 m vertical step size to a depth (
oof 120 m below the skull surface. For 3D videos, 23 sequential
image stacks were acquired at 5 m z spacing to cover a volume N
of 210 m × 210 m × 110 m (1 stack/min). Z stacks were pro- B
cessed with Lasersharp (Bio-Rad), Confocal Assistant (freeware), M
Volocity (Improvision, Coventry, UK), and custom-scripted macros l
in Adobe Photoshop (Leung, 2002). To assess the role of Gαi in TCM E
diapedesis, 5 × 107 TCMs were treated with PTX, labeled with BHoechst 33342 (5 g/ml; Sigma), and coinjected i.v. with an equal
Snumber of untreated TCMs labeled with 10 M Cell Tracker Orange t(CMTMR; Molecular Probes). 3 hr later, mice were prepared for MP-
1IVM while maintaining the tissue temperature at 37°C by placing a
Bheated circulating water loop and a microthermistor on the skull.
CFluorescent dyes were swapped between experiments.
e
tCytokine Production
pCD45.2+ lymphocytes from spleens and LNs of OT-IxRAG−/− or
P14xTCRα−/− donors were differentiated into TCMs and 5 × 106 cells C
injected i.v. into CD45.1+ recipients. 8 weeks later, animals were l
sacrificed, and single-cell suspensions from recipient spleens and c
BM were incubated with specific or control peptide (1 g/ml; 5 hr D
at 37°C). During the last 2 hr, 1 M brefeldin A was added, and Y
IFN-γ and IL-2 production of CD45.2+ cells was examined by FACS f
using a Cytofix/Cytoper kit (PharMingen) and mAbs to IFN-γ and d
IL-2. 2
DStatistical Analysis
a
For comparison of two samples, a two-tailed Student’s t test was
I
used. Multiple comparisons were performed by one-way ANOVA
Dwith Bonferroni correction. Significance was set at p < 0.05. Data
bin figures and tables are shown as mean ± SEM unless otherwise
indicated. E
I
a
sSupplemental Data
Supplemental Data include Supplemental Experimental Pro- F
cedures, Supplemental References, one table, one figure, and four I
movies and can be found with this article online at http://www. s
immunity.com/cgi/content/full/22/2/259/DC1. p
M
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